KIDS

OrthoPediatrics Corp. (KIDS) Porter's 5 Forces Analysis (2026)

Invetso Score: 5/10 — Balanced · Last Updated: 2026-08-01

Overall Score

Threat Of New Entrants

High gross margin profile (73.7% TTM) suggests some brand/pricing power, but the business is not protected by strong profitability.

A very high current ratio (4.78x) and low debt-to-equity (0.27x) reduce financial fragility, but do not create a strong entry barrier.

Negative operating margins and weak cash generation indicate the company is still vulnerable to competitive pressure rather than insulated from it.

Bargaining Power Of Suppliers

Inventory intensity is elevated, with days inventory outstanding at 754 days, which can increase dependence on suppliers and working-capital strain.

Payables outstanding (121.9 days) exceed receivables outstanding (88.0 days), suggesting the company is able to stretch supplier terms to some extent.

No material change in supplier leverage is evident from the latest metrics.

Bargaining Power Of Buyers

Negative net margin (-15.7%) and weak operating profitability imply limited ability to pass through costs to customers.

Revenue per share remains modest relative to valuation, while price-to-sales of 2.52x suggests investors still expect some demand resilience.

The company’s strong gross margin helps offset buyer pressure, but it is not enough to eliminate it.

Threat Of Substitutes

Persistent losses and weak returns on capital suggest the product set faces meaningful substitution or commoditization pressure.

Gross margin remains healthy, which implies the offering still has some differentiation versus alternatives.

No new evidence this month materially changes the substitute threat assessment.

Industry Rivalry

Operating margin is negative (-9.0%) and EBIT margin is negative (-10.6%), indicating a competitive environment that is still pressuring profitability.

The company’s liquidity is strong, but free cash flow remains negative, limiting room for aggressive competitive investment.

High inventory days and a long cash conversion cycle (720 days) point to operational inefficiency that can intensify rivalry.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on OrthoPediatrics Corp.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →